VRXA
Veraxa Biotech AG - Ordinary Shares (VRXA)
$13
About Veraxa Biotech AG - Ordinary Shares (VRXA)
Veraxa Biotech Holding AG engages in operating an oncology-focused biotechnology company, which is the Veraxa Biotech AG (Company). The Company focuses on the development of novel antibody-based drug platforms for the treatment of cancer. The company was founded on June 25, 2025 and is headquartered in Zurich, Switzerland.
Details
Daily high
$1.15
Daily low
$1.10
Price at open
$1.15
52 Week High
$27.36
52 Week Low
$1.10
Market cap
175.8M
Dividend yield
-
Volume
150,318
Avg. volume
288,234
P/E ratio
5.56
Veraxa Biotech AG - Ordinary Shares News
Details
Daily high
$1.15
Daily low
$1.10
Price at open
$1.15
52 Week High
$27.36
52 Week Low
$1.10
Market cap
175.8M
Dividend yield
-
Volume
150,318
Avg. volume
288,234
P/E ratio
5.56